MSH|^~\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|LADOH|LA|201608270130||ORU^R01|20160827033322978055|P|2.3.1||||||||PID|1|358569|23825200290^^^^^LabCorp Birmingham&01D0301471&CLIA|           CD- 1509377H113|HepTest^R3||19760112|F||U|12345 Hepatitis Reportable ROAD^^BOGALUSA^LA^70427||^^^^^985^9999999|||||||||U||||||||NK1|1||||||||||||||||||||||||||||||||||||ORC|||||||||||||||||||||Washington Community Center|2807 S Columbia St^^BOGALUSA^LA^70427|^^^^^985^7307310|2807 S Columbia St^^BOGALUSA^LA^70427OBR|1||23825200290|^^^322744^Hepatitis Panel (4)^L|||201608241439|||||||201608251514||1821355637^HARVEY^KEISHA^D'ANDREA^^^^^^^^^NPI|^^^^^985^7307310||||||||F||||||||||||||||||||OBX|1|CE|5196-1^Hepatitis B virus surface Ag^LN^006510^HBsAg Screen^L||R-40759^Negative^SNM^N^Negative^L||Negative||||F|||20160826094020|01D0301471^LabCorp Birmingham^CLIA||^EIANTE|1|L|Negative|OBX|2|CE|24113-3^Hepatitis B virus core Ab.IgM^LN^016881^Hep B Core Ab, IgM^L||G-A200^Positive^SNM^P^Positive^L||Negative|A|||F|||20160826094020|01D0301471^LabCorp Birmingham^CLIA||^EIANTE|1|L|Positive|NTE|2|L|.|OBX|3|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff^LN^140689^Hep C Virus Ab^L||>^11.0|s/co ratio|0.0-0.9|H|||F|||20160826094020|01D0301471^LabCorp Birmingham^CLIA||^EIANTE|1|L|                                                 Negative:     < 0.8|NTE|2|L|                                            Indeterminate: 0.8 - 0.9|NTE|3|L|                                                 Positive:     > 0.9|NTE|4|L|                                                                     .|NTE|5|L|                The CDC recommends that a positive HCV antibody result|NTE|6|L|                be followed up with a HCV Nucleic Acid Amplification|NTE|7|L|                test (550713).|NTE|8|L|.|